Article
Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting
12 Nov 2009
Abstract excerpt
Vesicular stomatitis virus (VSV) has long been regarded as a promising recombinant vaccine platform and oncolytic agent but has not yet been tested in humans because it causes encephalomyelitis in rodents and primates. Recent studies have shown that specific tropisms of several viruses could be eliminated by engineering microRNA target sequences into their genomes, thereby inhibiting spread in tissues expressing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
